News September 14, 2012 Tech Council of Maryland quietly promotes Jacoby to top spot – Baltimore Business Journal Art Jacoby’s turn as chief of the Tech Council of Maryland was intended as a… Super User 0 Love0
News September 14, 2012 Looking for Cures Lost in Translation In a recent article in Slate magazine’s Future Tense project, Pascal Zachary made a key… Super User 0 Love0
News September 14, 2012 Biotechnology Development Grants – FY2013 Awards (up to $200K) Applications Now Available Deadline to Apply: October 17, 2012 at 5:00 p.m. The Maryland Biotechnology Center’s (MBC) Biotechnology Development… Super User 0 Love0
News September 12, 2012 RxAnte gets $4.6M investment – Washington Business Journal McLean-based RxAnte, developing technologies that help make sure people take their prescription drugs, has received… Super User 0 Love0
News September 12, 2012 Mapping The Next Three Decades of Health Technology | Co.Exist: World changing ideas and innovation When science fiction films depict the future, the best writers and directors are often less… Super User 0 Love0
News September 12, 2012 U.S. Life-Sciences Valuations Creeping Upward, Law Firm Says – Venture Capital Dispatch – WSJ Law firm Fenwick & West, which handles legal issues for a variety of technology companies, has… Super User 0 Love0
News September 12, 2012 MedImmune preparing for Gaithersburg campus expansion Representatives for Gaithersburg biotech company MedImmune hinted at an expansion of their campus at a… Super User 0 Love0
News September 12, 2012 Nancy Floreen to talk economic development at White House – Maryland Politics – The Washington Post Montgomery County Council member Nancy Floreen has been invited by the White House to attend… Super User 0 Love0
News September 11, 2012 Tech Council of Maryland MdBio Leadership Breakfast Focuses on Issues of Importance to Maryland’s Biotech Industry – MarketWatch Peter Greenleaf, president of MedImmune, the Gaithersburg, Maryland-based global biologics arm of AstraZeneca, addressed many… Super User 0 Love0
News September 11, 2012 MedImmune, WuXi AppTec to develop new biologic for China – Pharmaceutical Business Review AstraZeneca biologics arm MedImmune and WuXi AppTec have formed a joint venture (JV) to develop… Super User 0 Love0